A practical reference on research chemical: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-03-19 and is reviewed periodically as new material appears.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
| Property | Value | Notes |
|---|---|---|
| Synonyms | SR9009; Stenabolic | Stenabolic is an informal name |
| Common form | Crystalline powder | Supplied in milligram to gram quantities |
| Long-term storage | -20 °C, desiccated, protected from light | Reduces degradation |
| Detection technique | LC-MS/MS | Common in anti-doping and research analysis |
| Regulatory status | Prohibited in sport by WADA | Not approved for human therapeutic use |
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
== Enterprises == SIP Animation, originally Saban International Paris, France based TV production company Société genevoise d'instruments de physique, Swiss manufacturer of precision machinery Société Immobilière Publique, a state-owned housing company in Burundi Società Italiana per l'Esercizio Telefonico (originally Società Idroelettrica Piemontese), the former name of Telecom Italia Selznick International Pictures, a defunct film studio
=== GPV / IIIa (GPV / IIa = integrin α5β1) === This is a heterodimer. Its α5 subunit is 36% identical to the GPIIb subunit. This complex is located mainly on endothelial cells but also on smooth muscle cells, macrophages and platelets. Its main function is in the adhesion of cells to the extracellular matrix components.
== Signs and symptoms == The following are symptoms characteristic with individuals having the disorder. Individuals may display some, most, or all of these symptoms throughout the course of their life, though symptoms may vary with each patient.
=== Differential diagnosis === Several disorders share some characteristics with EDS. For example, in cutis laxa, the skin is loose, hanging, and wrinkled. In EDS, the skin can be pulled away from the body, but is elastic and returns to normal when let go. In Marfan syndrome, the joints are very mobile, and similar cardiovascular complications occur. People with a "marfanoid" appearance are often tall and thin with long arms and legs and "spidery" fingers, while EDS phenotypes vary considerably. Certain subtypes of EDS may involve short stature, large eyes, and the appearance of a small mouth and chin, due to a small palate. The palate can have a high arch, causing dental crowding. Blood vessels can sometimes be easily seen through translucent skin, especially on the chest. The genetic connective tissue disorder Loeys–Dietz syndrome also has symptoms that overlap with EDS. In the past, Menkes disease, a copper metabolism disorder, was thought to be a form of EDS. People are commonly misdiagnosed with fibromyalgia, bleeding disorders, or other disorders that can mimic EDS symptoms. Because of these similar disorders and complications that can arise from an unmonitored case of EDS, a correct diagnosis is important. Pseudoxanthoma elasticum is worth consideration in diagnosis.
Wound healing is classically divided into hemostasis, inflammation, proliferation, and remodeling. Although a useful construct, this model employs considerable overlapping among individual phases. A complementary model has recently been described where the many elements of wound healing are more clearly delineated. The importance of this new model becomes more apparent through its utility in the fields of regenerative medicine and tissue engineering (see Research and development section below). In this construct, the process of wound healing is divided into two major phases: the early phase and the cellular phase: Electrospun nanofiber-based wound dressings have attracted increasing attention because their porous architecture and high surface-area-to-volume ratio can mimic the extracellular matrix, thereby supporting cell adhesion, proliferation, and tissue regeneration. The early phase, which begins immediately following skin injury, involves cascading molecular and cellular events leading to hemostasis and formation of an early, makeshift extracellular matrix that provides structural staging for cellular attachment and subsequent cellular proliferation. The cellular phase involves several types of cells working together to mount an inflammatory response, synthesize granulation tissue, and restore the epithelial layer. Subdivisions of the cellular phase are:
Sources: en.wikipedia.org
Glycyl-prolyl-hydroxyproline (Gly-Pro-Hyp, Tripeptide-29) is a tripeptide that is derived from collagen. Repeating units of Gly-Pro-Hyp form a major part of collagen protein, and Gly-Pro-Hyp can be readily produced by partial hydrolysis of collagen. Along with other collagen-derived small peptides such as the dipeptides Hyp-Gly and Pro-Hyp, Gly-Pro-Hyp is widely used in skincare products and sometimes taken internally as a dietary supplement, as it is readily absorbed into the skin and stimulates collagen synthesis by fibroblasts, which aids wound healing and may help to reduce signs of aging. Dietary supplements marketed as containing "collagen" often actually contain low molecular weight collagen peptides derived from partial hydrolysis of collagen, as they are better absorbed into the body than collagen itself.
Orthorhombic AmCl2: a = 896.3±0.8 pm, b = 757.3±0.8 pm and c = 453.2±0.6 pm Tetragonal AmBr2: a = 1159.2±0.4 pm and c = 712.1±0.3 pm. They can also be prepared by reacting metallic americium with an appropriate mercury halide HgX2, where X = Cl, Br or I:
Trimebutine nitroarginate and derivatives – arginine nitro-derivative acts as a nitric oxide donor, which exerts anti-inflammatory effect (similarly to naproxcinod) Trimebutine thiocarbamoylbenzoate – thioamide group acts as a hydrogen sulfide donor, also acting as an anti-inflammatory and analgesic agent
== Signs and symptoms == Pain is not typically present in pellucid marginal degeneration, and aside from vision loss, no symptoms accompany the condition. However, in rare cases, PMD may present with sudden onset vision loss and excruciating eye pain, which occurs if the thinning of the cornea leads to perforation. While PMD usually affects both eyes, some unilateral cases have been reported. PMD is characterized by bilateral thinning (ectasia) in the inferior and peripheral region of the cornea. The distribution of the degeneration is crescent or arcuate shaped. The cornea just above the region of thinning is of normal thickness, and may protrude anteriorly, which creates an irregular astigmatism. This is described as a "beer belly" appearance since the greatest protrusion occurs below the horizontal midline (unlike keratoconus). Normally, PMD does not present with vascularization of the cornea, scarring, or any deposits of lipid.
(K11.4) Salivary gland fistula (K31.6) Fistula of stomach and duodenum (K31.6) Gastrocolic fistula (K31.6) Gastrojejunocolic fistula – after a Billroth II a fistula forms between the transverse colon and the upper jejunum (which, post Billroth II, is attached to the remainder of the stomach). Fecal matter passes improperly from the colon to the stomach and causes halitosis. Enterocutaneous fistula: between the intestine and the skin surface, namely from the duodenum or the jejunum or the ileum. This definition excludes the fistulas arising from the colon or the appendix. Gastric fistula: from the stomach to the skin surface (K38.3) Fistula of appendix (K60) Anal and rectal fissures and fistulas (K60.3) Anal fistula (K60.5) Anorectal fistula (fecal fistula, fistula-in-ano): connecting the rectum or other anorectal area to the skin surface. This results in abnormal discharge of feces through an opening other than the anus. (K63.2) Fistula of intestine Enteroenteral fistula: between two parts of the intestine (K82.3) Fistula of gallbladder (K83.3) Fistula of bile duct Biliary fistula: connecting the bile ducts to the skin surface, often caused by gallbladder surgery Pancreatic fistula: between the pancreas and the exterior via the abdominal wall
Sources: en.wikipedia.org
== Molecular origins == Momentum transport in gases is mediated by discrete molecular collisions, and in liquids by attractive forces that bind molecules close together. Because of this, the dynamic viscosities of liquids are typically much larger than those of gases. In addition, viscosity tends to increase with temperature in gases and decrease with temperature in liquids. Above the liquid-gas critical point, the liquid and gas phases are replaced by a single supercritical phase. In this regime, the mechanisms of momentum transport interpolate between liquid-like and gas-like behavior. For example, along a supercritical isobar (constant-pressure surface), the kinematic viscosity decreases at low temperature and increases at high temperature, with a minimum in between. Kostya Trachenko and Vadim Brazhkin provided a rough estimate for the value at the minimum, given by
Robbins (1963), psychiatrist, scholar on expatriate communities in India Richard Waldinger (1963), computer scientist, fellow of the Association for the Advancement of Artificial Intelligence Allan Blaer (1964), physicist and professor who is in charge of the Columbia University Science Honors Program Frederick Kantor (1964), physicist, inventor of glancing incidence X-ray telescope Richard A. Muller (1964), professor of physics at the University of California, Berkeley; winner of the MacArthur Fellowship in 1982 and the Alan T. Waterman Award in 1978; founder of climate science institute Berkeley Earth Kenneth Prager (1964), physician, professor at Columbia University Medical Center, brother of commentator Dennis Prager Mark C. Rogers (1964), physician, former CEO of Duke University Health System Michael Terman (1964), Columbia University Medical Center psychologist Norman Christ (1965), physicist, professor at Columbia University Niles Eldredge (1965), collaborator of Stephen Jay Gould and curator of the Department of Invertebrates at the American Museum of Natural History Alan I. Green (1965), professor at Geisel School of Medicine, nephew of Herman Wouk Stuart Newman (1965), developmental and evolutionary biologist Allen Steere (1965), rheumatologist and pioneering investigator of Lyme disease Sylvain Cappell (1966), mathematician, professor at the Courant Institute of Mathematical Sciences Barry S.
Maggot therapy has been shown to accelerate debridement of necrotic wounds and reduce the bacterial load of the wound, leading to earlier healing, reduced wound odor and less pain. The combination and interactions of these actions make maggots an extremely potent tool in chronic wound care. Negative pressure wound therapy (NPWT) is a treatment that improves ischemic tissues and removes wound fluid used by bacteria. This therapy, also known as vacuum-assisted closure, reduces swelling in tissues, which brings more blood and nutrients to the area, as does the negative pressure itself. The treatment also decompresses tissues and alters the shape of cells, causes them to express different mRNAs and to proliferate and produce ECM molecules. Recent technological advancements produced novel approaches such as self-adaptive wound dressings that rely on properties of smart polymers sensitive to changes in humidity levels. The dressing delivers absorption or hydration as needed over each independent wound area and aids in the natural process of autolytic debridement. It effectively removes liquefied slough and necrotic tissue, disintegrated bacterial biofilm as well as harmful exudate components, known to slow the healing process. The treatment also reduces bacterial load by effective evacuation and immobilization of microorganisms from the wound bed, and subsequent chemical binding of available water that is necessary for their replication.
=== Mechanism of action === Flunarizine is a selective calcium antagonist with moderate other actions including antihistamine, serotonin receptor blocking and dopamine D2 blocking activity. Compared to other calcium channel blockers such as dihydropyridine derivatives, verapamil and diltiazem, flunarizine has low affinity to voltage-dependent calcium channels. It has been theorised that it may act not by inhibiting calcium entry into cells, but rather by an intracellular mechanism such as antagonising calmodulin, a calcium binding protein.
The Gamat, which is a Malay word for sea cucumber (holothuroidea), refers to medicinal remedies derived from several species of the sea cucumber family. It has been used traditionally by the Malays and local indigenous in Malaysia to relieve back pain, treating bruise, minor wounds and burns, as well as a tonic to provide extra energy to the body. A research conduct by Universiti Malaysia Sabah (UMS) in 2007 to find out the usage of traditional medicine among the ethnic groups in Sabah in a public market in the eastern coast of Tawau District found that the Bugis with the most usage with 40%, followed by Sama-Bajau with 28%, with Gamat oil (minyak gamat) and Eucalyptus oil (minyak kayu putih) are most commonly used by the community.
Sources: en.wikipedia.org
Laboratories commonly use liquid chromatography coupled with mass spectrometry to detect SR9009. The method can identify the compound and estimate concentration in a sample. Detection limits depend on the matrix and instrument.
Research-grade purity indicates a supplier's measured percentage of the intended compound. It does not guarantee safety, sterility, or suitability for human consumption. Buyers should request a certificate of analysis with chromatograms and test methods.
Sports regulators prohibit SR9009 because it is a non-approved substance with potential performance-altering effects. Its presence can be detected in anti-doping testing. Athletes are responsible for substances found in their samples.
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.